Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Accelerated atherosclerosis in inflammatory rheumatic diseases.

D O Haskard1

  • 1The Eric Bywaters Centre for Vascular Inflammation, Imperial College London, Hammersmith Hospital, United Kingdom. d.haskard@imperial.ac.uk

Scandinavian Journal of Rheumatology
|October 30, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A low balance between microparticles expressing tissue factor pathway inhibitor and tissue factor is associated with thrombosis in Behçet's Syndrome.

Scientific reports·2016
Same author

The exaggerated inflammatory response in Behçet's syndrome: identification of dysfunctional post-transcriptional regulation of the IFN-γ/CXCL10 IP-10 pathway.

Clinical and experimental immunology·2015
Same author

Methotrexate-mediated activation of an AMPK-CREB-dependent pathway: a novel mechanism for vascular protection in chronic systemic inflammation.

Annals of the rheumatic diseases·2015
Same author

Pegylated interferon-α-2b reduces corticosteroid requirement in patients with Behçet's disease with upregulation of circulating regulatory T cells and reduction of Th17.

Annals of the rheumatic diseases·2014
Same author

Poly(ADP-ribose) polymerase family member 14 (PARP14) is a novel effector of the JNK2-dependent pro-survival signal in multiple myeloma.

Oncogene·2012
Same author

Persistence of TNFalpha in diabetic wounds.

Diabetologia·2010

Patients with inflammatory rheumatic diseases face higher risks of atherosclerosis due to inflammation and specific immune responses. This review explores key mechanisms driving this accelerated cardiovascular risk.

Area of Science:

  • Rheumatology
  • Cardiovascular Medicine
  • Immunology

Background:

  • Inflammatory rheumatic diseases are linked to increased atherosclerosis risk.
  • Both general inflammation and disease-specific immune mechanisms contribute.
  • Understanding these links is crucial for patient outcomes.

Purpose of the Study:

  • To review proposed mechanisms of accelerated atherosclerosis in rheumatic diseases.
  • To highlight the interplay between inflammation, immunity, and cardiovascular disease.
  • To consolidate current knowledge on this significant comorbidity.

Main Methods:

  • Literature review of proposed mechanisms.
  • Synthesis of information on inflammatory and immune pathways.
  • Discussion of factors contributing to atherogenesis.

Related Experiment Videos

Main Results:

  • Accelerated atherosclerosis is associated with abnormal lipid profiles.
  • Oxidative stress, apoptosis, and thrombophilia play significant roles.
  • Immune complexes and cytokine generation are implicated in lesion development.

Conclusions:

  • Inflammation and specific immune responses in rheumatic diseases promote atherosclerosis.
  • Multiple molecular and cellular mechanisms contribute to this increased cardiovascular risk.
  • Further research into these pathways may reveal therapeutic targets.